Ovata Capital Management LTD Global Blood Therapeutics, Inc. Transaction History

Ovata Capital Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$22.3 - $37.39 $490,510 - $822,430	-21,996 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$25.68 - $35.59 $96,762 - $134,103	-3,768 Reduced 14.63%	21,996 $762,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $268,023 - $433,358	10,764 Added 71.76%	25,764 $754,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $114,660 - $168,030	4,500 Added 42.86%	15,000 $382,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $97,380 - $130,260	3,000 Added 40.0%	10,500 $368,000

Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $292,050 - $381,375	7,500 New	7,500 $306,000
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $113,961 - $160,898	-2,160 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$48.73 - $81.82 $105,256 - $176,731	2,160 New	2,160 $136,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Ovata Capital Management LTD with notifications on news.